Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice
Mian Xie, Xiao-Jun Wu, Jin-jun Zhang, et al.
Oncotarget (2015) Vol. 6, Iss. 32, pp. 32902-32913
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Beatriz Ballester, Javier Milara, Julio Cortijo
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 593-593
Open Access | Times Cited: 259
A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma
Diego Bagnasco, Matteo Ferrando, Gilda Varricchi, et al.
International Archives of Allergy and Immunology (2016) Vol. 170, Iss. 2, pp. 122-131
Open Access | Times Cited: 201
The Two Sides of YY1 in Cancer: A Friend and a Foe
Sailu Sarvagalla, Srinivasa Prasad Kolapalli, Sivakumar Vallabhapurapu
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 150
Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies
Jing Wang, Zhijie Luo, Lizhu Lin, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4791-4791
Open Access | Times Cited: 69
The roles of the Hippo pathway in cancer metastasis
Helena J. Janse van Rensburg, Xiaolong Yang
Cellular Signalling (2016) Vol. 28, Iss. 11, pp. 1761-1772
Closed Access | Times Cited: 101
Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy
Karin M. Knudson, SuJin Hwang, Mondona S. McCann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment
Yin Li, Manling Jiang, Ling Aye, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Targeting anoikis resistance as a strategy for cancer therapy
Yumin Wang, Sihang Cheng, Joshua S. Fleishman, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101099-101099
Closed Access | Times Cited: 11
IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells
Hui Cao, Jing Zhang, Hong Liu, et al.
Oncotarget (2016) Vol. 7, Iss. 38, pp. 61183-61198
Open Access | Times Cited: 82
Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma
Katarzyna C. Pituch, Jason Miska, Giedre Krenciute, et al.
Molecular Therapy (2018) Vol. 26, Iss. 4, pp. 986-995
Open Access | Times Cited: 70
IL-13 receptor α2 stimulates human glioma cell growth and metastasis through the Src/PI3K/Akt/mTOR signaling pathway
Ming Tu, Wei Wange, Lin Cai, et al.
Tumor Biology (2016) Vol. 37, Iss. 11, pp. 14701-14709
Closed Access | Times Cited: 51
Roles of IL-4, IL-13, and Their Receptors in Lung Cancer
Yao Zhang, Kangle Zhu, Xiao Wang, et al.
Journal of Interferon & Cytokine Research (2024) Vol. 44, Iss. 9, pp. 399-407
Closed Access | Times Cited: 4
Inflammatory cytokines and specific factors influencing lung cancer progression
Md. Shalahuddin Millat, Md. Mahmudul Hasan, Mohammad Sarowar Uddin, et al.
Cancer Pathogenesis and Therapy (2025)
Open Access
Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy
Lawrence A. Stern, Sharareh Gholamin, Ignacio Moraga, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 33
Open Access | Times Cited: 16
A comparative study of the arazyme-based fusion proteins with various ligands for more effective targeting cancer therapy
Rezvan Mehrab, Hamid Sedighian, Fattah Sotoodehnejadnematalahi, et al.
Research in Pharmaceutical Sciences (2023) Vol. 18, Iss. 2, pp. 159-176
Open Access | Times Cited: 8
IRS-1 targets TAZ to inhibit adipogenesis of rat bone marrow mesenchymal stem cells through PI3K-Akt and MEK-ERK pathways
Na Wang, Yukun Li, Ziyi Li, et al.
European Journal of Pharmacology (2019) Vol. 849, pp. 11-21
Closed Access | Times Cited: 25
IRS-1 increases TAZ expression and promotes osteogenic differentiation in rat bone marrow mesenchymal stem cells
Na Wang, Peng Xue, Ziyi Li, et al.
Biology Open (2018) Vol. 7, Iss. 12
Open Access | Times Cited: 24
Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis
Marwa O. El-Derany
Biology (2020) Vol. 9, Iss. 4, pp. 75-75
Open Access | Times Cited: 20
Cigarette smoke extracts induce overexpression of the proto-oncogenic gene interleukin-13 receptor α2 through activation of the PKA-CREB signaling pathway to trigger malignant transformation of lung vascular endothelial cells and angiogenesis
Mei Meng, Huaidong Liao, Bin Zhang, et al.
Cellular Signalling (2016) Vol. 31, pp. 15-25
Closed Access | Times Cited: 18
Tristetraprolin exerts tumor suppressive functions on the tumorigenesis of glioma by targeting IL-13
Bo Zeng, Danhua Zhu, Zhipeng Su, et al.
International Immunopharmacology (2016) Vol. 39, pp. 63-70
Closed Access | Times Cited: 17
Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide
Riaz Jannoo, Zhidao Xia, Paula E. Row, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 356-356
Open Access | Times Cited: 5
Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy
Dharambir Kashyap, Huda Salman
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3780-3780
Open Access | Times Cited: 1
Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future?
Fengqin Liu, Xia Miao, Lu Han, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model
Parul Gupta, Ziyue Karen Jiang, Bing Yang, et al.
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Extracellular vesicles extracted from bone marrow mesenchymal stem cells carrying MicroRNA-342-3p inhibit the INHBA/IL13Rα2 axis to suppress the growth and metastasis of breast cancer
Qi Liu, Jing Zhang, Yi Liu, et al.
Translational Oncology (2022) Vol. 18, pp. 101333-101333
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top